Contact information
Research groups
Lisa Stockdale
MPH, PhD
Senior Immunologist
Pre-erythrocytic Malaria and Outbreak Pathogen Clinical Trials
Senior Immunologist
Senior immunologist in the pre-erythrocytic malaria vaccine group. I coordinate the immunology of a Phase 3 vaccine clinical trial on R21/Matrix M.
Research interests include correlates of vaccine-induced protection, antibody glycosylation and immunological interactions between different pathogens.
I am an Early Career Researcher representative for NDM and a lead of the Jenner Research Staff Network.
Recent publications
-
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Journal article
Datoo MS. et al, (2024), Lancet (London, England), 403, 533 - 544
-
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
Journal article
Schmit N. et al, (2024), The Lancet. Infectious diseases
-
Distinct glycosylation and functional profile of typhoid vaccine-induced antibodies in a UK challenge study and Nepalese children
Journal article
Stockdale LK. et al, (2022), Frontiers in Analytical Science, 2
-
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
Journal article
Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716
-
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Journal article
Tomic A. et al, (2022), Nature Communications, 13